Dr. Lal Pathlabs Q4 Results Live : profit rise by 49.17% YOY

Dr. Lal Pathlabs Q4 Results Live : Dr. Lal Pathlabs declared their Q4 results on 10 May, 2024, showing a remarkable performance. The company's revenue increased by 11.08% year-over-year, indicating strong growth in their top line.

The profit also saw a significant surge of 49.17% year-over-year, highlighting the company's strong financial health and operational efficiency.

In comparison to the previous quarter, Dr. Lal Pathlabs witnessed a growth of 1.21% in revenue and 3.94% in profit, showcasing a consistent positive trajectory in their financial results.

The Selling, general & administrative expenses showed a decline of 3.05% quarter-over-quarter, however, they increased by 12.17% year-over-year, which is an important aspect to monitor for cost management.

The operating income of the company was up by 3.35% quarter-over-quarter and increased by 38.69% year-over-year, indicating strong operational performance and efficiency.

The Earnings Per Share (EPS) for Q4 stood at ₹10.12, marking a significant increase of 48.47% year-over-year, reflecting positively on the company's profitability and shareholder value.

Despite the positive financial results, Dr. Lal Pathlabs has delivered negative returns in the last 1 week, last 6 months, and year-to-date, which might be a point of concern for investors.

Currently, the company has a market capitalization of ₹18569.41 Cr with a 52-week high/low of ₹2767.1 & ₹1888.1 respectively, indicating the stock's price volatility over the past year.

Analysts covering the company have mixed recommendations, with a consensus recommendation to Hold the stock as of 12 May, 2024. It's essential for investors to consider these analyst ratings along with the financial performance before making investment decisions.